Currently Running Studies

QLT: Phase III, Radical Study, single masked study comparing reduced-fluence Visudyne-Lucentis. Combination therapies and Lucentis monotherapy in subjects with CNV secondary to AMD.

Principal Investigator: Miguel Busquets, MD,FACS
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD

Regeneron: Phase III, View Study, double masked active controlled study of the efficacy, safety and tolerability of repeated doses of intravitreal VEGF trap in patients with neovascular ARMD.

Principal Investigator: Miguel Busquets, MD, FACS 
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD, Lisa Cibik, MD, FACS, Alberto Guardiola, MD

Novartis: Phase III, Denali Study, double masked study assessing safety and efficacy of (Visudyne) photodynamic therapy in conjunction with (Lucentis) versus Lucentis monotherapy in patients with subfoveal choroidal neovascularization secondary to ARMD.

Principal Investigator: Miguel Busquets, MD, FACS 
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD, Alberto Guardiola, MD

Genentech: Phase III, Ride Study, controlled study of the efficacy and safety of Ranibizumab injection in subjects with clinically significant macular edema with center involvement secondary to DM.

Principal Investigator: Brian Jewart, MD 
Sub-Investigators: Miguel Busquets, MD, FACS, Martin Boscarino, MD

Alimera: Phase III, Fame Study, double masked comparison of the safety and efficacy of Fluocinolone Acetonide intravitreal inserts to sham injection in patients with DME.

Principal Investigator: Miguel Busquets, MD, FACS 
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD

Alimera: Phase III, Famous Study, Fluocinolone Acetonide intravitreal inserts in subjects with DME.

Principal Investigator: Miguel Busquets, MD, FACS
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD

Glaukos: Phase III, iStent Study, trabecular bypass micro stent in combination with cataract surgery in subjects with open-angle glaucoma.

Principal Investigator: John Nairn, MD

Ophthotech: Phase I Study; evaluate the safety and pharmacokinetic profile of multiple intravitreous Volociximab injection alone or in combination with Lucentis in subjects with subfoveal neovascularization secondary to AMD.

Principal Investigator: Miguel Busquets, MD,FACS 
Sub-Investigators: Brian Jewart MD, Martin Boscarino, MD, Alberto Guardiola, MD

Alcon: Phase III, Nevanac Study, a clinical safety and efficacy comparison of Nevanac 0.1% to vehicle following cataract surgery in diabetic retinopathy patients.

Principal Investigator: Lisa Cibik, MD,FACS 
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD, Miguel Busquets, MD, FACS

Eli-Lilly (Parexel): Phase III, Ruboxistaurin Study: The effect of Ruboxistaurin on clinically significant macular edema patients with diabetes mellitus as assessed by OCT.

Principal Investigator: Miguel Busquets, MD, FACS 
Sub-Investigators: Brian Jewart, MD, Martin Boscarino, MD, Alberto Guardiola,MD

Alcon: Phase III, Treatment of Bacterial Conjunctivitis Study, An evaluation of the safety and efficacy of Moxifloxacin AF Ophthalmic Solution 0.5%.

Principal Investigator: Lisa Cibik, MD, FACS 
Sub-Investigators: John Nairn, MD, Daniel Zimmer, MD, FACS

Bausch & Lomb : Phase III, Corticosteroid Ointment compared to vehicle for the treatment of inflammation following cataract surgery.

Principal Investigator: Lisa Cibik, MD, FACS
Sub-Investigators: Daniel Zimmer, MD, FACS, John Nairn, MD

QLT: Phase II, An Open-Label, Phase 2 Study of punctal placement of the Latanoprost Punctal Plug System open-angle glaucoma (OAG)

Principal Investigator: John Nairn, MD
Sub-Investigators: Lisa Cibik, MD, FACS, Daniel Zimmer, MD, FACS

Macugen: Pan-retinal laser Endophotocoagulation for the treatment of proliferative diabetic retinopathy.

Triple Therapy Study: An Evaluation of the safety and efficacy of Triple Therapy for subfoveal choroidal neovascularization (CNV) secondary to age related macular degeneration (ARMD).

Contact information:

Michelle L. Colwell, COT, CCRC
9970 Mountain View Drive, 2nd Floor 
West Mifflin, PA 15122 
mcolwell@aioeyesurgeons.com
Phone: 412-653-3080 x1041
Cell: 412-651-4476
Fax: 412-653-3698